Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

ClinicalTrials.gov ID: NCT01636817

Public ClinicalTrials.gov record NCT01636817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 11:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double Blind, Placebo-controlled, Multiple Dose, Phase 2b, 24 Week Trial Followed by an Open Label Extension of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

Study identification

NCT ID
NCT01636817
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
239 participants

Conditions and interventions

Interventions

  • NNC0109-0012 Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2012
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
Sep 4, 2018

2012 – 2014

United States locations

U.S. sites
92
U.S. states
32
U.S. cities
84
Facility City State ZIP Site status
Novo Nordisk Investigational Site Huntsville Alabama 35801
Novo Nordisk Investigational Site Tuscaloosa Alabama 35406
Novo Nordisk Investigational Site Mesa Arizona 85202
Novo Nordisk Investigational Site Phoenix Arizona 85037
Novo Nordisk Investigational Site Scottsdale Arizona 85258-4523
Novo Nordisk Investigational Site Glendale California 91204
Novo Nordisk Investigational Site Hemet California 92543
Novo Nordisk Investigational Site Huntington Beach California 92646
Novo Nordisk Investigational Site La Mesa California 91942
Novo Nordisk Investigational Site Lakewood California 90712
Novo Nordisk Investigational Site Long Beach California 90806
Novo Nordisk Investigational Site Long Beach California 90808-2146
Novo Nordisk Investigational Site Los Angeles California 90022
Novo Nordisk Investigational Site Placentia California 92870
Novo Nordisk Investigational Site San Diego California 92101
Novo Nordisk Investigational Site Santa Monica California 90409
Novo Nordisk Investigational Site Upland California 91786
Novo Nordisk Investigational Site Boca Raton Florida 33486
Novo Nordisk Investigational Site Fort Lauderdale Florida 33334
Novo Nordisk Investigational Site Gainesville Florida 32607
Novo Nordisk Investigational Site Jupiter Florida 33468
Novo Nordisk Investigational Site New Port Richey Florida 34652
Novo Nordisk Investigational Site Ocala Florida 34474
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site Tampa Florida 33613
Novo Nordisk Investigational Site Venice Florida 34292
Novo Nordisk Investigational Site West Palm Beach Florida 33407
Novo Nordisk Investigational Site Decatur Georgia 30033
Novo Nordisk Investigational Site Idaho Falls Idaho 83404
Novo Nordisk Investigational Site Rock Island Illinois 61201
Novo Nordisk Investigational Site Springfield Illinois 62704
Novo Nordisk Investigational Site South Bend Indiana 46601
Novo Nordisk Investigational Site Cedar Rapids Iowa 52401-2112
Novo Nordisk Investigational Site Kansas City Kansas 66160
Novo Nordisk Investigational Site Wichita Kansas 67206
Novo Nordisk Investigational Site Elizabethtown Kentucky 42701-2988
Novo Nordisk Investigational Site Lake Charles Louisiana 70601
Novo Nordisk Investigational Site Shreveport Louisiana 71105
Novo Nordisk Investigational Site Baltimore Maryland 21239
Novo Nordisk Investigational Site Columbia Maryland 21045
Novo Nordisk Investigational Site Cumberland Maryland 21502
Novo Nordisk Investigational Site Hagerstown Maryland 21740
Novo Nordisk Investigational Site Worcester Massachusetts 01605
Novo Nordisk Investigational Site Ann Arbor Michigan 48109-0100
Novo Nordisk Investigational Site Battle Creek Michigan 49018
Novo Nordisk Investigational Site Flowood Mississippi 39232-9306
Novo Nordisk Investigational Site Flowood Mississippi 39232
Novo Nordisk Investigational Site St Louis Missouri 63117
Novo Nordisk Investigational Site St Louis Missouri 63139-2338
Novo Nordisk Investigational Site St Louis Missouri 63141-6819
Novo Nordisk Investigational Site Lincoln Nebraska 68516
Novo Nordisk Investigational Site Clifton New Jersey 07012
Novo Nordisk Investigational Site Freehold New Jersey 07728
Novo Nordisk Investigational Site Toms River New Jersey 08755
Novo Nordisk Investigational Site Albuquerque New Mexico 87102
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site Brooklyn New York 11201-4326
Novo Nordisk Investigational Site Lake Success New York 11042
Novo Nordisk Investigational Site Chapel Hill North Carolina 27599
Novo Nordisk Investigational Site Charlotte North Carolina 28210
Novo Nordisk Investigational Site Greensboro North Carolina 27408
Novo Nordisk Investigational Site Raleigh North Carolina 27617
Novo Nordisk Investigational Site Wilmington North Carolina 28401-6442
Novo Nordisk Investigational Site Cincinnati Ohio 45219
Novo Nordisk Investigational Site Columbus Ohio 43203
Novo Nordisk Investigational Site Toledo Ohio 43606
Novo Nordisk Investigational Site Norman Oklahoma 73069
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103
Novo Nordisk Investigational Site Tulsa Oklahoma 74135
Novo Nordisk Investigational Site Bend Oregon 97701
Novo Nordisk Investigational Site Lake Oswego Oregon 07035
Novo Nordisk Investigational Site Hershey Pennsylvania 17033-2360
Novo Nordisk Investigational Site Charleston South Carolina 29406
Novo Nordisk Investigational Site Charleston South Carolina 29407-7757
Novo Nordisk Investigational Site Columbia South Carolina 29204-2409
Novo Nordisk Investigational Site Orangeburg South Carolina 29118
Novo Nordisk Investigational Site Jackson Tennessee 38305
Novo Nordisk Investigational Site Memphis Tennessee 38104
Novo Nordisk Investigational Site Memphis Tennessee 38119
Novo Nordisk Investigational Site Amarillo Texas 79124
Novo Nordisk Investigational Site Austin Texas 78721
Novo Nordisk Investigational Site Carrollton Texas 75007
Novo Nordisk Investigational Site Houston Texas 77008
Novo Nordisk Investigational Site Houston Texas 77034
Novo Nordisk Investigational Site Houston Texas 77090
Novo Nordisk Investigational Site McKinney Texas 75071
Novo Nordisk Investigational Site Sugar Land Texas 77479
Novo Nordisk Investigational Site Waco Texas 76708-3244
Novo Nordisk Investigational Site Arlington Virginia 22205
Novo Nordisk Investigational Site Seattle Washington 98122
Novo Nordisk Investigational Site Tacoma Washington 98405
Novo Nordisk Investigational Site Beckley West Virginia 25801-2805

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01636817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2018 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01636817 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →